Balyasny Asset Management
FLGT icon

Balyasny Asset Management’s Fulgent Genetics FLGT Stock Holding History

Balyasny Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,097
Closed -$320K – 3077
2025
Q2 		$320K Sell
16,097
-53,329
-77% -$1.04M ﹤0.01% 2464
2025
Q1 		$1.17M Buy
69,426
+43,113
+164% +$734K ﹤0.01% 1927
2024
Q4 		$486K Buy
+26,313
New +$514K ﹤0.01% 2202
2024
Q2 		– Sell
-10,994
Closed -$239K – 2736
2024
Q1 		$239K Buy
+10,994
New +$273K ﹤0.01% 2342
2023
Q3 		– Sell
-8,609
Closed -$319K – 2404
2023
Q2 		$319K Buy
+8,609
New +$300K ﹤0.01% 1974
2023
Q1 		– Sell
-13,700
Closed -$408K – 2820
2022
Q4 		$408K Sell
13,700
-20,333
-60% -$728K ﹤0.01% 1907
2022
Q3 		$1.3M Buy
34,033
+1,331
+4% +$66.7K ﹤0.01% 1694
2022
Q2 		$1.78M Buy
+32,702
New +$1.8M 0.01% 1475
2021
Q4 		– Sell
-2,962
Closed -$266K – 2356
2021
Q3 		$266K Buy
+2,962
New +$269K ﹤0.01% 1612

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Balyasny Asset Management's FLGT Position: Q3 2025 in Review

Balyasny Asset Management sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 16,097 shares — an estimated $320K sold.

Balyasny Asset Management first reported a position in FLGT in Q3 2021 and held it in 9 quarters. The position peaked at $1.78M in Q2 2022. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Balyasny Asset Management reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 16,097 Fulgent Genetics shares in Q3 2025, an estimated $320K.
  • Balyasny Asset Management first reported a position in Fulgent Genetics in Q3 2021 and held it in 9 quarters.
  • Balyasny Asset Management's Fulgent Genetics position peaked at $1.78M in Q2 2022.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.